Analysts predict EPS of -$0.01 for HashiCorp Inc (HCP)’s current quarter

After finishing at $26.95 in the prior trading day, HashiCorp Inc (NASDAQ: HCP) closed at $25.81, down -4.23%. In other words, the price has decreased by -$1.14 from its previous closing price. On the day, 1979916 shares were traded. HCP stock price reached its highest trading level at $26.93 during the session, while it also had its lowest trading level at $25.78.

Ratios:

Our goal is to gain a better understanding of HCP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

On March 12, 2024, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $31.

Morgan Stanley Upgraded its Equal-Weight to Overweight on February 26, 2024, whereas the target price for the stock was revised from $23 to $30.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 22 ’24 when Dadgar Armon sold 35,904 shares for $27.09 per share. The transaction valued at 972,629 led to the insider holds 1,697,068 shares of the business.

Dadgar Armon sold 25,956 shares of HCP for $703,122 on Mar 22 ’24. The CHIEF TECHNOLOGY OFFICER now owns 118,864 shares after completing the transaction at $27.09 per share. On Mar 22 ’24, another insider, Welihinda Navam, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 21,223 shares for $27.09 each. As a result, the insider received 574,931 and left with 62,844 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCP now has a Market Capitalization of 5.15B and an Enterprise Value of 3.89B. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.87 while its Price-to-Book (P/B) ratio in mrq is 4.24. Its current Enterprise Value per Revenue stands at 6.66 whereas that against EBITDA is -15.87.

Stock Price History:

Over the past 52 weeks, HCP has reached a high of $36.39, while it has fallen to a 52-week low of $18.91. The 50-Day Moving Average of the stock is 24.88, while the 200-Day Moving Average is calculated to be 24.39.

Shares Statistics:

The stock has traded on average 2.47M shares per day over the past 3-months and 1.6M shares per day over the last 10 days, according to various share statistics. A total of 125.33M shares are outstanding, with a floating share count of 112.16M. Insiders hold about 44.02% of the company’s shares, while institutions hold 47.33% stake in the company. Shares short for HCP as of Mar 15, 2024 were 6.46M with a Short Ratio of 2.61, compared to 5.45M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.24% and a Short% of Float of 5.24%.

Earnings Estimates

Its stock is currently analyzed by 17 different market analysts. On average, analysts expect EPS of -$0.01 for the current quarter, with a high estimate of $0.01 and a low estimate of -$0.03, while EPS last year was -$0.07. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.03 and low estimates of -$0.03.

Analysts are recommending an EPS of between $0.2 and $0.01 for the fiscal current year, implying an average EPS of $0.07. EPS for the following year is $0.27, with 18 analysts recommending between $0.62 and $0.1.

Revenue Estimates

A total of 17 analysts have provided revenue estimates for HCP’s current fiscal year. The highest revenue estimate was $647.04M, while the lowest revenue estimate was $643.61M, resulting in an average revenue estimate of $645.56M. In the same quarter a year ago, actual revenue was $583.14M, up 10.70% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $754.72M in the next fiscal year. The high estimate is $777.51M and the low estimate is $730.7M. The average revenue growth estimate for next year is up 16.90% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]